Business Description
Aptahem AB
ISIN : SE0006543450
Compare
Compare
Traded in other countries / regions
APTA.Sweden IPO Date
2015-04-17Description
Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main candidate Apta-1 is developed as an emergency medicine intended to prevent the occurrence of life-threatening organ and tissue damage in patients suffering from sepsis.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.42 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.5 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 46.7 | |||||
| 3-Year EPS without NRI Growth Rate | 45.2 | |||||
| 3-Year FCF Growth Rate | 24.9 | |||||
| 3-Year Book Growth Rate | -8.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.04 | |||||
| 9-Day RSI | 34.11 | |||||
| 14-Day RSI | 35.2 | |||||
| 6-1 Month Momentum % | -78.67 | |||||
| 12-1 Month Momentum % | -79.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.45 | |||||
| Quick Ratio | 0.45 | |||||
| Cash Ratio | 0.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -40.3 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -19.17 | |||||
| ROA % | -16.94 | |||||
| ROIC % | -16.62 | |||||
| ROC (Joel Greenblatt) % | -6321.03 | |||||
| ROCE % | -17.43 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.14 | |||||
| EV-to-EBIT | -1.61 | |||||
| EV-to-EBITDA | -1.63 | |||||
| EV-to-FCF | -1.32 | |||||
| Earnings Yield (Greenblatt) % | -62.12 | |||||
| FCF Yield % | -96.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aptahem AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.054 | ||
| Beta | 0 | ||
| Volatility % | 89.27 | ||
| 14-Day RSI | 35.2 | ||
| 14-Day ATR (kr) | 0.004575 | ||
| 20-Day SMA (kr) | 0.03093 | ||
| 12-1 Month Momentum % | -79.14 | ||
| 52-Week Range (kr) | 0.024 - 0.241666 | ||
| Shares Outstanding (Mil) | 451.46 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aptahem AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aptahem AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aptahem AB Frequently Asked Questions
What is Aptahem AB(XSAT:APTA)'s stock price today?
The current price of XSAT:APTA is kr0.03. The 52 week high of XSAT:APTA is kr0.24 and 52 week low is kr0.02.
When is next earnings date of Aptahem AB(XSAT:APTA)?
The next earnings date of Aptahem AB(XSAT:APTA) is 2024-05-31.
Does Aptahem AB(XSAT:APTA) pay dividends? If so, how much?
Aptahem AB(XSAT:APTA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers